ESH Video

#ESHLYMPHOMA2024 PROGRAMME HIGHLIGHT: ROUNDTABLE 1 ON DIFFUSE LARGE B CELL LYMPHOMA

July 25, 2024

 

4th How to Diagnose and Treat


LYMPHOMA

 

November 1-3, 2024

Stockholm, Sweden

#ESHLYMPHOMA2024

Chairpersons: Christian Buske (Ulm), Michael Crump (Toronto),
Gilles Salles (New York), Catherine Thieblemont (Paris)

 

 


 

PROGRAMME HIGHLIGHT: ROUNTABLE 1

 

Diffuse large B cell lymphoma

 


Chair: Gilles Salles (New York)


Optimizing treatment outcomes using biomarker-driven approaches
by Sirpa Leppä (Helsinki)

Primary CNS lymphoma: When to use an intensive therapy approach
by Anca Prica (Toronto)


(followed by discussion)


Friday, November 1, 2024 / 18:35-19:15

 


 

About the Conference:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.

They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.

 

 

 


 

CONFERENCE MAIN SCIENTIFIC TOPICS

• Aggressive B cell lymphomas: Diffuse large B cell lymphoma,
High grade B cell lymphoma and Burkitt
• Mantle cell lymphoma
• Challenging T cell lymphomas
• Mantle Cell lymphoma: Optimal cellular therapy for
relapsed disease CAR T vs AlloSCT
• Diffuse large B cell lymphoma
• Diffuse large B-cell lymphoma: Immune based therapy
• Novelties in marginal zone lymphoma and Waldenström macroglobulinemia
• What is the optimal regimen for advanced Hodgkin’s lymphoma?
• Chronic lymphocytic leukemia
• Follicular Lymphoma
• Bispecific VS Car-T
• Immune environment in Hodgkin’s lymphoma

 


 

CALL FOR ABSTRACTS & CLINICAL CASES
Deadline:  August 19th, 2024

 
Clinical Cases and abstracts are eligible to be selected for an oral or a poster presentation.

 


 

To read the preliminary programme, click here!

For more information, click here!

 


 

With the support of*:


Major Conference Partner
*******

AstraZeneca

Level 1 Conference Partners
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.